Changes

Jump to: navigation, search

Speculative timeline of future malaria events

121 bytes removed, 07:54, 17 November 2019
no edit summary
| 2023 || Eradication || About 16 million lives are expected to be saved, and 234 million infections are expected to be averted by that year, after announcement by the Global Fund to Fight AIDS, Tuberculosis and Malaria of having raised US$14.02 billion for its next three-year funding cycle.<ref name="The RBM Partnership to End Malaria leads global malaria community in celebrating successful Global Fund replenishment">{{cite web |title=The RBM Partnership to End Malaria leads global malaria community in celebrating successful Global Fund replenishment |url=https://endmalaria.org/news/rbm-partnership-end-malaria-leads-global-malaria-community-celebrating-successful-global-fund |website=endmalaria.org |accessdate=17 November 2019}}</ref> || Worldwide || {{w|Global Fund to Fight AIDS, Tuberculosis and Malaria}} || Project || October 10, 2019
|-
| 2024 || Vaccine || The Global Malaria Vaccines Market, by Vaccine Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine), by Agent (''{{w|Plasmodium Falciparum}}'', ''{{w|Plasmodium Vivax}}''), and by Distribution Channel (Hospitals, Clinics, Community Centers) is expected to be valued at US$ 50.6 million in this year.<ref name="nbc29.com">{{cite web |title=At 150.0% CAGR, Malaria Vaccines Market to Surge past US$ 790.7 Million by 2027 | Key Findings, Regional Analysis, and Key Players GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biot |url=https://www.nbc29.com/story/40957707/at-1500-cagr-malaria-vaccines-market-to-surge-past-us-7907-million-by-2027-key-findings-regional-analysis-and-key-players-glaxosmithkline-plc-sanaria |website=nbc29.com |accessdate=17 November 2019}}</ref> || || || Estimate || August, 2019
|-
| 2024 || Vaccine || {{w|RTS,S/AS01}} (trade name Mosquirix) is expected to be marketed in this year.<ref name="nbc29.com"/> || || || Project || August, 2019
62,434
edits

Navigation menu